Shares in German generic drugmaker Stada slumped on Tuesday after a 5.3 billion euro ($5.9 billion) agreed takeover bid by private equity groups Bain Capital and Cinven did not win enough shareholder support.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
